EURO-ELSAV



Availability web pages

World Bank background papers
Economics of AIDS vaccines. A number of links to World Bank policy papers
Medicines for Malaria Venture
WHO's new MMV is a joint public-private sector initiative which aims to develop antimalarial drugs and drug combinations for distribution in poor countries
Global Malaria Initiatives
Malaria, Economics, and Human Affairs
CID's Malaria, Economics, and Human Affairs project investigates the economic consequences of malaria endemicity, and the ways in which economic analysis may be brought to bear in ameliorating the enormous burden of this disease. The project is multidisciplinary in scope, drawing upon the input of clinicians, epidemiologists, public health specialists, scientists and economists from across Harvard's faculty and beyond.
Medicines sans frontieres access to essential medicines campaign
Jeffrey Sachs's article in the Economist proposing a purchase fund for vaccines
The Case for a Vaccine Purchase Fund
Global forum for health
Policy analysis of the use of hepatitis b, Haemophilus influenzae type b-, Streptococcal pneumonia- conjugate and rotavirus vaccines in national immunisation schedules
World Bank Health page
Public/private partnership: developing an oral treatment for visceral leishmaniasis
Setting the scene for miltefosine Phase III clinical trials: Nina Mattock reports from a kala-azar clinic in Bihar, India

This page was last updated Saturday, 17-Apr-2004 23:31:09 CEST